E2Z.F 9.14 (+2.24%)
ES0157097017Drug ManufacturersDrug Manufacturers - Specialty & Generic

Almirall (E2Z.F) Stock Highlights

9.14 | +2.24%
2024-10-21 01:55:10
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the companys operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Statistics

Range Today
9.14 9.14
Volume Today 0
Range 1 Year
7.79 9.95
Volume 1 Year 2.23K
Range 3 Year
7.43 13.15
Volume 3 Year 21.91K
Range 10 Year
7.3013 18.7719
Volume 10 Year 301.51K

Highlights

Market Capitalization 2.16B (mid)
Floating Shares 76.88M
Current Price 9.14
Price To Earnings -48.11
Price To Revenue 2.18
Price To Book 1.31
Earnings Per Share -0.19
Dividend Yield 2.06%
Dividend Per Share 0.18
Payout Ratio 116.25%

Performance

Latest +2.24%
1 Month +7.78%
3 Months +2.01%
6 Months +14.25%
1 Year +1.44%
3 Years -29.04%
5 Years -43.57%
10 Years -20.58%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.